SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Techniclone (TCLN) -- Ignore unavailable to you. Want to Upgrade?

To: shero who wrote (842)12/10/1997 4:32:00 PM
From: john dixon  Read Replies (3) | Respond to of 3702
 
check todays news on tcln, santoro appointed to board of directors of a ca. co. what is the connection (hankin)?



To: shero who wrote (842)12/10/1997 6:21:00 PM
From: EZLibra  Respond to of 3702
 
Shero. Highlight of the Day. Results of P II for Idec and Coulter in Low Grade NHL: IDPH (Rituxan/Y2B8) 14 of 17 PR, no breakdown of CR; Coulter 27 of 45 PR, including 14 CR. Techniclone's Low Grade results in Phase II were 14 of 19 PR, including 5 CR. Not bad for a secondary indication. I think TCLN will be heard from in Low Grade.


HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2026 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News